Company Filing History:
Years Active: 1993-1994
Title: Heinrich Estermann: Innovator in Stereoisomer Preparation
Introduction
Heinrich Estermann is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of stereochemistry, particularly in the preparation of stereoisomers that have pharmacological applications. With a total of 2 patents, Estermann's work is recognized for its innovative approaches and practical applications.
Latest Patents
Estermann's latest patents focus on the use of the (R) isomer of 2,2-bis(hydroxmethyl)-tetrahydrofuran monobutyrate. The first patent describes a process for preparing the (R) stereoisomer by subjecting the dibutyric ester of 2,2-bis(hydroxymethyl)-tetrahydrofuran to enzymatic hydrolysis. This invention not only relates to the novel (R) stereoisomer produced but also to its more stable forms. Furthermore, it discusses the use of the (R) stereoisomer in preparing stereoisomers of pharmacologically active compounds, highlighting its importance in medicinal chemistry.
Career Highlights
Estermann is currently associated with Sandoz GmbH, a global leader in generic pharmaceuticals. His work at Sandoz has allowed him to focus on innovative processes that enhance the efficiency and effectiveness of drug development. His contributions have been instrumental in advancing the field of stereochemistry.
Collaborations
Heinrich Estermann has collaborated with notable colleagues such as Prasad Koteswara Kapa and Russell L Underwood. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Heinrich Estermann's work in the preparation of stereoisomers has made a lasting impact on the pharmaceutical industry. His innovative processes and collaborations continue to drive advancements in drug development and stereochemistry.